T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection

Archives of Neurology

Volumn 56, Issue 1, 1999, Pages 79-83

  Schneider, Christiane ^a   Dalakas, Marinos C ^b   Toyka, Klaus V ^a   Said, Gérard ^c   Hartung, Hans Peter ^a   Gold, Ralf ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; T LYMPHOCYTE ANTIBODY;

ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL DEATH; COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY INFILTRATE; INTERMETHOD COMPARISON; MUSCLE BIOPSY; NERVE BIOPSY; POLYMYOSITIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURAL NERVE; T LYMPHOCYTE;

APOPTOSIS; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROMUSCULAR DISEASES; POLYMYOSITIS; T-LYMPHOCYTES;

EID: 0032938286     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.1.79     Document Type: Article

References (27)

1. Pender MP, Nguyen KB, McCombe PA, Kerr JF. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci. 1991;104:81-87.
2. Schmied M, Breitschopf H, Gold . Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol. 1993;143:446-452.
3. Zettl UK, Gold R, Hartung HP, Toyka KV. Apoptotic cell death of lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci Lett. 1994;176:75-79.
4. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 1994;117:1311-1322.
5. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM. Miedema F. Programmed death of T cells in HIV infection. Science. 1992;257:217-219.
6. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol. 1995;154:5555-5565.
7. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré-syndrome-part I. Muscle Nerve. 1995;18:137-164.
8. Schneider C, Gold R, Dalakas MC, et al. MHC class-I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis and inclusion body myositis. J Neuropathol Exp Neurol. 1996;55:1205-1209.
9. Kerr JFR, Wyllie AH, Currie A. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
10. Wyllie AH, Kerr JFR, Currie AR, Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
11. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 1994;71:219-225.
12. Dalakas MC, Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325:1487-1498.
13. Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Annu Rev Med. 1993;44:211-219.
14. Behrens L, Bender A, Johnson MA, Hoblfeld R. Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibers and inflammatory cells. Brain. 1997;120:929-938.
15. Dalakas MC, Cupler EJ. Neuropathies in HIV infection. In: Hartung HP, ed. Ballière's Clinical Neurology: Peripheral Neuropathies. Part II. Vol 5. London. England: Ballière Tindall: 1996:199-218.
16. Illa I, Nath A, Dalakas MC. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol. 1991;29:474-481.
17. Leon-Monzon M, Lamperth L, Dalakas MC. Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve. 1993;16:408-413.
18. Glass JD, Johnson RT. Human immunodeficiency virus and the brain. Annu Rev Neurosci. 1996;19:1-26.
19. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol. 1996;39:392-395.
20. + T cells. J Exp Med. 1995;181:1863-1868.
21. Mantegazza R, Andreetta F, Bernasconi P, et al. Analysis of T-cell receptor repertoire of muscle-infiltrating T-lymphocytes in polymyositis: restricted alpha/beta rearrangements may indicate antigen-driven selection J Clin Invest. 1993;91:2880-2886.
22. Gold R, Hartung HP, Lassmann H. T cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 1997;20:399-404.
23. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med. 1995;181:2029-2035.
24. Ameisen JC, Estaquier J, Idziorek T, De Bels F. The relevance of apoptosis to AIDS pathogenesis. Trends Cell Biol. 1995;5:27-32.
25. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95 mediated apoptosis by HIV-1 tat and gp120. Nature. 1995;375:497-500.
26. + T cells, modulated by cytokines and effected by lymphotoxin. AIDS. 1996;10:603-611.
27. Ffrench-Constant C, Pathogenesis of multiple sclerosis. Lancet. 1994;343:271-275.